|Pronunciation||klor zox' a zone|
|Trade names||Lorzone, Paraflex, Muscol, others|
|Drug class||Muscle relaxant|
|Main uses||Low back pain, muscle spasms|
|Side effects||Dizziness, sleepiness, headache, tremor|
|Onset of action||With 1 hr|
|Duration of action||Up to 4 hr|
|Elimination half-life||1.1 hr|
|Chemical and physical data|
|Molar mass||169.56 g·mol−1|
|3D model (JSmol)|
Chlorzoxazone, sold under the brand names Lorzone among others, is a muscle relaxant used to treat low back pain and muscle spasms. Benefits are moderate. It is not useful for neurological problems such as cerebral palsy. It is taken by mouth. Effects begin within an hour and last for up to 4 hours.
Common side effects include dizziness, sleepiness, headache, and tremor. Other side effects may include liver problems and angioedema. Safety in pregnancy is unclear. It works at the level of the spinal cord and brain.
Chlorzoxazone was approved for medical use in the United States in 1958. It is available as a generic medication. In the United States 60 pills of 500 mg costs about 18 USD as of 2022. As of 2017 it remains widely used.
The usual recommended dose in adults is 250 to 750 mg by mouth three to four times daily, reducing the dose to lowest effective level once a response occurs. It is typically given for 1 to 4 weeks only.
- "Chlorzoxazone". Retrieved 4 January 2022.
- "Chlorzoxazone Monograph for Professionals". Drugs.com. Retrieved 4 January 2022.
- "Parafon DSC- chlorzoxazone tablet". DailyMed. 9 February 2010. Retrieved 5 November 2020.
- "Lorzone- chlorzoxazone tablet". DailyMed. 21 June 2019. Retrieved 5 November 2020.
- "Chlorzoxazone Prices, Coupons & Savings Tips - GoodRx". GoodRx. Retrieved 4 January 2022.
- Dong DL, Luan Y, Feng TM, Fan CL, Yue P, Sun ZJ, Gu RM, Yang BF (2006). "Chlorzoxazone inhibit contraction of rat thoracic aorta". Eur J Pharmacol. 545 (2–3): 161–6. doi:10.1016/j.ejphar.2006.06.063. PMID 16859676.
- Park J, Kim K, Park P, Ha J (2006). "Effect of high-dose aspirin on CYP2E1 activity in healthy subjects measured using chlorzoxazone as a probe". J Clin Pharmacol. 46 (1): 109–14. doi:10.1177/0091270005282635. PMID 16397290. S2CID 20092326.
- Wan J, Ernstgård L, Song B, Shoaf S (2006). "Chlorzoxazone metabolism is increased in fasted Sprague-Dawley rats". J Pharm Pharmacol. 58 (1): 51–61. doi:10.1211/jpp.58.1.0007. PMC 1388188. PMID 16393464.